CCDC115 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.915440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.117200E-01
Normal-vs-Stage2
2.078800E-01
Normal-vs-Stage3
1.220640E-01
Normal-vs-Stage4
8.821400E-01
Stage1-vs-Stage2
9.821200E-01
Stage1-vs-Stage3
3.768600E-01
Stage1-vs-Stage4
2.614200E-01
Stage2-vs-Stage3
1.854760E-01
Stage2-vs-Stage4
9.029700E-02
Stage3-vs-Stage4
4.832000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.591240E-01
Normal-vs-AfricanAmerican
2.469600E-01
Normal-vs-Asian
5.954400E-01
Caucasian-vs-AfricanAmerican
8.391600E-01
Caucasian-vs-Asian
8.289200E-01
AfricanAmerican-vs-Asian
8.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.788990E-01
Normal-vs-Female
2.217000E-01
Male-vs-Female
9.509000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.405400E-01
Normal-vs-Age(41-60Yrs)
3.168000E-01
Normal-vs-Age(61-80Yrs)
1.703970E-01
Normal-vs-Age(81-100Yrs)
4.147000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.517400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.668400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.220000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.736100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.607400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.299000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.563200E-01
Normal-vs-Daily Drinker
4.569000E-01
Normal-vs-Weekly Drinker
2.351400E-01
Normal-vs-Occasional Drinker
5.816800E-01
Normal-vs-Social Drinker
2.571800E-01
Non Drinker-vs-Daily Drinker
2.599800E-01
Non Drinker-vs-Weekly Drinker
9.937600E-01
Non Drinker-vs-Occasional Drinker
5.537500E-02
Non Drinker-vs-Social Drinker
5.588400E-01
Daily Drinker-vs-Weekly Drinker
3.089800E-01
Daily Drinker-vs-Occasional Drinker
4.956200E-01
Daily Drinker-vs-Social Drinker
4.408000E-02
Weekly Drinker-vs-Occasional Drinker
8.978100E-02
Weekly Drinker-vs-Social Drinker
6.449400E-01
Occasional Drinker-vs-Social Drinker
2.104500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.312200E-01
Normal-vs-Grade 2
4.141600E-02
Normal-vs-Grade 3
4.861200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.839940E-02
Grade 1-vs-Grade 3
4.444200E-02
Grade 1-vs-Grade 4
2.312200E-01
Grade 2-vs-Grade 3
6.763600E-01
Grade 2-vs-Grade 4
4.141600E-02
Grade 3-vs-Grade 4
4.861200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.045200E-01
Normal-vs-NonDiabetic
2.126800E-01
Diabetic-vs-NonDiabetic
6.572400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.151000E-01
Normal-vs-NoPancreatitis
1.917050E-01
Pancreatitis-vs-NoPancreatitis
4.336000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.406000E-01
Normal-vs-N1
1.932780E-01
N0-vs-N1
9.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.181200E-01
Normal-vs-TP53-NonMutant
1.205180E-01
TP53-Mutant-vs-TP53-NonMutant
1.89449999998814E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
